Hospitals participating in certain voluntary valued-based reforms have reduced their readmissions more than hospitals participating in only the mandatory Hospital Readmissions Reduction Program, according to a study reported today in JAMA Internal Medicine. Based on readmissions data for 2,837 hospitals between 2008 and 2015, the study found that hospitals achieving meaningful use under the Medicare and Medicaid Electronic Health Records Incentive Programs or participating in Medicare’s accountable care organizations or Bundled Payment for Care Initiative achieved greater reductions in readmissions under the HRRP. Participation in more than one of the three voluntary programs led to additional improvement. Hospitals participating in all three voluntary programs reduced their readmissions by an additional 1.27 percentage points for heart attack, 1.64 percentage points for heart failure and 1.05 percentage points for pneumonia. The authors estimate that hospital participation in the three voluntary programs in 2015 led to 2,377 fewer readmissions, saving Medicare more than $32.7 million.

Related News Articles

Headline
The Joint Commission June 30 announced a new, streamlined process that removes 714 requirements from its hospital accreditation program. The new program,…
Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
The U.S. District Court for the Eastern District of Texas March 31 ruled that the Food and Drug Administration does not have the authority to regulate…